Correlation Between Hepion Pharmaceuticals and Champions Oncology
Can any of the company-specific risk be diversified away by investing in both Hepion Pharmaceuticals and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hepion Pharmaceuticals and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hepion Pharmaceuticals and Champions Oncology, you can compare the effects of market volatilities on Hepion Pharmaceuticals and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hepion Pharmaceuticals with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hepion Pharmaceuticals and Champions Oncology.
Diversification Opportunities for Hepion Pharmaceuticals and Champions Oncology
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Hepion and Champions is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding Hepion Pharmaceuticals and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Hepion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hepion Pharmaceuticals are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Hepion Pharmaceuticals i.e., Hepion Pharmaceuticals and Champions Oncology go up and down completely randomly.
Pair Corralation between Hepion Pharmaceuticals and Champions Oncology
Given the investment horizon of 90 days Hepion Pharmaceuticals is expected to under-perform the Champions Oncology. In addition to that, Hepion Pharmaceuticals is 3.23 times more volatile than Champions Oncology. It trades about -0.11 of its total potential returns per unit of risk. Champions Oncology is currently generating about 0.25 per unit of volatility. If you would invest 820.00 in Champions Oncology on November 3, 2024 and sell it today you would earn a total of 279.00 from holding Champions Oncology or generate 34.02% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Hepion Pharmaceuticals vs. Champions Oncology
Performance |
| Timeline |
| Hepion Pharmaceuticals |
| Champions Oncology |
Hepion Pharmaceuticals and Champions Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Hepion Pharmaceuticals and Champions Oncology
The main advantage of trading using opposite Hepion Pharmaceuticals and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hepion Pharmaceuticals position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
| Champions Oncology vs. Molecular Partners AG | Champions Oncology vs. MediciNova | Champions Oncology vs. Anebulo Pharmaceuticals | Champions Oncology vs. Shattuck Labs |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |